Ailuropoda melanoleuca (giant panda): 100477326
Help
Entry
100477326 CDS
T01329
Gene name
PRKCA
Definition
(RefSeq) protein kinase C alpha type
KO
K02677
classical protein kinase C alpha type [EC:
2.7.11.13
]
Organism
aml
Ailuropoda melanoleuca (giant panda)
Pathway
aml01521
EGFR tyrosine kinase inhibitor resistance
aml04010
MAPK signaling pathway
aml04012
ErbB signaling pathway
aml04014
Ras signaling pathway
aml04015
Rap1 signaling pathway
aml04020
Calcium signaling pathway
aml04066
HIF-1 signaling pathway
aml04070
Phosphatidylinositol signaling system
aml04071
Sphingolipid signaling pathway
aml04072
Phospholipase D signaling pathway
aml04150
mTOR signaling pathway
aml04151
PI3K-Akt signaling pathway
aml04261
Adrenergic signaling in cardiomyocytes
aml04270
Vascular smooth muscle contraction
aml04310
Wnt signaling pathway
aml04360
Axon guidance
aml04370
VEGF signaling pathway
aml04510
Focal adhesion
aml04540
Gap junction
aml04613
Neutrophil extracellular trap formation
aml04650
Natural killer cell mediated cytotoxicity
aml04664
Fc epsilon RI signaling pathway
aml04666
Fc gamma R-mediated phagocytosis
aml04670
Leukocyte transendothelial migration
aml04713
Circadian entrainment
aml04720
Long-term potentiation
aml04723
Retrograde endocannabinoid signaling
aml04724
Glutamatergic synapse
aml04725
Cholinergic synapse
aml04726
Serotonergic synapse
aml04727
GABAergic synapse
aml04728
Dopaminergic synapse
aml04730
Long-term depression
aml04750
Inflammatory mediator regulation of TRP channels
aml04911
Insulin secretion
aml04912
GnRH signaling pathway
aml04916
Melanogenesis
aml04918
Thyroid hormone synthesis
aml04919
Thyroid hormone signaling pathway
aml04921
Oxytocin signaling pathway
aml04925
Aldosterone synthesis and secretion
aml04926
Relaxin signaling pathway
aml04928
Parathyroid hormone synthesis, secretion and action
aml04929
GnRH secretion
aml04933
AGE-RAGE signaling pathway in diabetic complications
aml04935
Growth hormone synthesis, secretion and action
aml04960
Aldosterone-regulated sodium reabsorption
aml04961
Endocrine and other factor-regulated calcium reabsorption
aml04970
Salivary secretion
aml04971
Gastric acid secretion
aml04972
Pancreatic secretion
aml05017
Spinocerebellar ataxia
aml05022
Pathways of neurodegeneration - multiple diseases
aml05031
Amphetamine addiction
aml05032
Morphine addiction
aml05143
African trypanosomiasis
aml05146
Amoebiasis
aml05161
Hepatitis B
aml05163
Human cytomegalovirus infection
aml05164
Influenza A
aml05170
Human immunodeficiency virus 1 infection
aml05171
Coronavirus disease - COVID-19
aml05200
Pathways in cancer
aml05205
Proteoglycans in cancer
aml05206
MicroRNAs in cancer
aml05214
Glioma
aml05223
Non-small cell lung cancer
aml05225
Hepatocellular carcinoma
aml05231
Choline metabolism in cancer
Brite
KEGG Orthology (KO) [BR:
aml00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100477326 (PRKCA)
04012 ErbB signaling pathway
100477326 (PRKCA)
04014 Ras signaling pathway
100477326 (PRKCA)
04015 Rap1 signaling pathway
100477326 (PRKCA)
04310 Wnt signaling pathway
100477326 (PRKCA)
04370 VEGF signaling pathway
100477326 (PRKCA)
04066 HIF-1 signaling pathway
100477326 (PRKCA)
04020 Calcium signaling pathway
100477326 (PRKCA)
04070 Phosphatidylinositol signaling system
100477326 (PRKCA)
04072 Phospholipase D signaling pathway
100477326 (PRKCA)
04071 Sphingolipid signaling pathway
100477326 (PRKCA)
04151 PI3K-Akt signaling pathway
100477326 (PRKCA)
04150 mTOR signaling pathway
100477326 (PRKCA)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
100477326 (PRKCA)
04540 Gap junction
100477326 (PRKCA)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
100477326 (PRKCA)
04650 Natural killer cell mediated cytotoxicity
100477326 (PRKCA)
04664 Fc epsilon RI signaling pathway
100477326 (PRKCA)
04666 Fc gamma R-mediated phagocytosis
100477326 (PRKCA)
04670 Leukocyte transendothelial migration
100477326 (PRKCA)
09152 Endocrine system
04911 Insulin secretion
100477326 (PRKCA)
04929 GnRH secretion
100477326 (PRKCA)
04912 GnRH signaling pathway
100477326 (PRKCA)
04921 Oxytocin signaling pathway
100477326 (PRKCA)
04926 Relaxin signaling pathway
100477326 (PRKCA)
04935 Growth hormone synthesis, secretion and action
100477326 (PRKCA)
04918 Thyroid hormone synthesis
100477326 (PRKCA)
04919 Thyroid hormone signaling pathway
100477326 (PRKCA)
04928 Parathyroid hormone synthesis, secretion and action
100477326 (PRKCA)
04916 Melanogenesis
100477326 (PRKCA)
04925 Aldosterone synthesis and secretion
100477326 (PRKCA)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
100477326 (PRKCA)
04270 Vascular smooth muscle contraction
100477326 (PRKCA)
09154 Digestive system
04970 Salivary secretion
100477326 (PRKCA)
04971 Gastric acid secretion
100477326 (PRKCA)
04972 Pancreatic secretion
100477326 (PRKCA)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100477326 (PRKCA)
04961 Endocrine and other factor-regulated calcium reabsorption
100477326 (PRKCA)
09156 Nervous system
04724 Glutamatergic synapse
100477326 (PRKCA)
04727 GABAergic synapse
100477326 (PRKCA)
04725 Cholinergic synapse
100477326 (PRKCA)
04728 Dopaminergic synapse
100477326 (PRKCA)
04726 Serotonergic synapse
100477326 (PRKCA)
04720 Long-term potentiation
100477326 (PRKCA)
04730 Long-term depression
100477326 (PRKCA)
04723 Retrograde endocannabinoid signaling
100477326 (PRKCA)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100477326 (PRKCA)
09158 Development and regeneration
04360 Axon guidance
100477326 (PRKCA)
09159 Environmental adaptation
04713 Circadian entrainment
100477326 (PRKCA)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100477326 (PRKCA)
05206 MicroRNAs in cancer
100477326 (PRKCA)
05205 Proteoglycans in cancer
100477326 (PRKCA)
05231 Choline metabolism in cancer
100477326 (PRKCA)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
100477326 (PRKCA)
05214 Glioma
100477326 (PRKCA)
05223 Non-small cell lung cancer
100477326 (PRKCA)
09164 Neurodegenerative disease
05017 Spinocerebellar ataxia
100477326 (PRKCA)
05022 Pathways of neurodegeneration - multiple diseases
100477326 (PRKCA)
09165 Substance dependence
05031 Amphetamine addiction
100477326 (PRKCA)
05032 Morphine addiction
100477326 (PRKCA)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
100477326 (PRKCA)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100477326 (PRKCA)
05161 Hepatitis B
100477326 (PRKCA)
05171 Coronavirus disease - COVID-19
100477326 (PRKCA)
05164 Influenza A
100477326 (PRKCA)
05163 Human cytomegalovirus infection
100477326 (PRKCA)
09174 Infectious disease: parasitic
05146 Amoebiasis
100477326 (PRKCA)
05143 African trypanosomiasis
100477326 (PRKCA)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100477326 (PRKCA)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
aml01001
]
100477326 (PRKCA)
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
aml04131
]
100477326 (PRKCA)
Enzymes [BR:
aml01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.13 protein kinase C
100477326 (PRKCA)
Protein kinases [BR:
aml01001
]
Serine/threonine kinases: AGC group
PKC family [OT]
100477326 (PRKCA)
Membrane trafficking [BR:
aml04131
]
Endocytosis
Lipid raft mediated endocytosis
Caveolin-mediated endocytosis
100477326 (PRKCA)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
C1_1
C2
Pkinase_C
C1_2
APH
Motif
Other DBs
NCBI-GeneID:
100477326
NCBI-ProteinID:
XP_002921765
Ensembl:
ENSAMEG00000011747
UniProt:
G1LZD5
LinkDB
All DBs
Position
13
AA seq
672 aa
AA seq
DB search
MADVFPANDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGF
GKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGS
LLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVTDEKLHVTVRDA
KNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRL
SVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNVE
LRQKFEKAKLGPAGNKVISPSEDRRQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKG
TEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYV
NGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIA
DFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG
EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPGKRLGCGPEGERDVREHAFFRRI
DWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVN
PQFVHPILQSAV
NT seq
2019 nt
NT seq
+upstream
nt +downstream
nt
atggctgacgttttcccggccaacgactccacggcgtctcaggacgtggccaaccgcttc
gcccgcaaaggggcgctgaggcagaagaacgtgcatgaggtgaaggaccacaaattcatc
gcccgcttcttcaagcagcccaccttctgcagccactgcaccgacttcatctgggggttt
gggaaacaaggcttccagtgccaagtttgctgttttgtggttcacaagaggtgccatgaa
tttgtcactttttcttgtccgggtgcggataagggacccgacaccgacgacccaagaagc
aagcacaagtttaaaatccacacttatggaagccccaccttctgtgatcactgtgggtcc
ttgctgtatggacttatccatcaagggatgaaatgtgacacctgcgacatgaacgtgcac
aaacagtgcgtgatcaacgtgcccagcctctgcgggatggaccacacggagaagaggggc
cggatctacctgaaggcggaggtcaccgacgagaagctccacgtcaccgtacgagatgca
aaaaatctaattcctatggatccaaatgggctttcagatccttatgtgaagctgaaactt
attcctgatcccaagaatgagagcaaacagaaaaccaaaaccatccgctccacactgaac
ccccagtggaatgagtcctttacattcaaattaaaaccttcggataaagaccgacggctg
tccgtagaaatctgggactgggatcgaacaactaggaatgatttcatggggtccctctcc
tttggagtctcggagctgatgaagatgccagccagcggatggtacaagctgcttaaccaa
gaggaaggtgagtactacaacgtgcccattccggaaggggacgaagaaggcaacgtggag
ctcaggcagaaattcgagaaagccaagcttggcccagctgggaacaaagtaatcagtcct
tcagaagacagaagacaaccttccaacaacctggacagagtgaaactcaccgacttcaat
ttcctcatggtgctggggaaggggagttttggaaaggtgatgcttgctgaccggaagggc
acagaggaactgtatgctatcaaaatcctgaagaaggatgtggtgattcaggatgacgac
gtggagtgcaccatggtggagaagcgagtcctagccctcctggacaagccgccgttcctg
acacagctacactcctgcttccagacagtggatcggctgtacttcgtcatggaatacgtc
aatggcggggacctcatgtaccacattcagcaagtaggaaaatttaaggaaccacaagca
gtattttatgcggcagagatttccattggattgttctttcttcataaaagaggaatcatt
tacagggatctgaagttagataatgtcatgctggattcagaagggcatatcaagattgcc
gattttgggatgtgcaaggaacacatgatggacggagtcacaaccaggaccttctgtggg
acgccagattacatcgccccagagataatcgcctatcagccgtatggaaaatctgtggac
tggtgggcctatggcgtcctgttgtatgaaatgctagctgggcagcctccctttgatggt
gaagatgaagacgagctgtttcagtccataatggagcataacgtttcttatcccaagtcc
ttgtccaaggaggccgtttccatctgcaagggactgatgaccaaacacccaggcaagcgg
ctgggttgcgggccggagggggagagggacgtgcgggaacatgccttcttccggaggatc
gactgggagaaactcgagaacagggagatccagccacccttcaagcccaaagtgtgtggc
aaaggcgcagaaaactttgacaagttcttcacgcgagggcagcctgtcttgacaccacct
gatcagctggtcattgctaacatagaccagtctgatttcgaggggttctcgtatgtcaac
ccccagtttgtgcaccccatcttacagagcgcagtatga
Ailuropoda melanoleuca (giant panda): 100478007
Help
Entry
100478007 CDS
T01329
Gene name
PRKCB
Definition
(RefSeq) protein kinase C beta type isoform X2
KO
K19662
classical protein kinase C beta type [EC:
2.7.11.13
]
Organism
aml
Ailuropoda melanoleuca (giant panda)
Pathway
aml01521
EGFR tyrosine kinase inhibitor resistance
aml04010
MAPK signaling pathway
aml04012
ErbB signaling pathway
aml04014
Ras signaling pathway
aml04015
Rap1 signaling pathway
aml04020
Calcium signaling pathway
aml04062
Chemokine signaling pathway
aml04064
NF-kappa B signaling pathway
aml04066
HIF-1 signaling pathway
aml04070
Phosphatidylinositol signaling system
aml04071
Sphingolipid signaling pathway
aml04150
mTOR signaling pathway
aml04270
Vascular smooth muscle contraction
aml04310
Wnt signaling pathway
aml04370
VEGF signaling pathway
aml04510
Focal adhesion
aml04540
Gap junction
aml04613
Neutrophil extracellular trap formation
aml04650
Natural killer cell mediated cytotoxicity
aml04662
B cell receptor signaling pathway
aml04666
Fc gamma R-mediated phagocytosis
aml04670
Leukocyte transendothelial migration
aml04713
Circadian entrainment
aml04720
Long-term potentiation
aml04723
Retrograde endocannabinoid signaling
aml04724
Glutamatergic synapse
aml04725
Cholinergic synapse
aml04726
Serotonergic synapse
aml04727
GABAergic synapse
aml04728
Dopaminergic synapse
aml04730
Long-term depression
aml04750
Inflammatory mediator regulation of TRP channels
aml04911
Insulin secretion
aml04912
GnRH signaling pathway
aml04916
Melanogenesis
aml04918
Thyroid hormone synthesis
aml04919
Thyroid hormone signaling pathway
aml04921
Oxytocin signaling pathway
aml04925
Aldosterone synthesis and secretion
aml04928
Parathyroid hormone synthesis, secretion and action
aml04929
GnRH secretion
aml04931
Insulin resistance
aml04933
AGE-RAGE signaling pathway in diabetic complications
aml04935
Growth hormone synthesis, secretion and action
aml04960
Aldosterone-regulated sodium reabsorption
aml04961
Endocrine and other factor-regulated calcium reabsorption
aml04970
Salivary secretion
aml04971
Gastric acid secretion
aml04972
Pancreatic secretion
aml04973
Carbohydrate digestion and absorption
aml05017
Spinocerebellar ataxia
aml05022
Pathways of neurodegeneration - multiple diseases
aml05031
Amphetamine addiction
aml05032
Morphine addiction
aml05140
Leishmaniasis
aml05143
African trypanosomiasis
aml05146
Amoebiasis
aml05161
Hepatitis B
aml05163
Human cytomegalovirus infection
aml05164
Influenza A
aml05170
Human immunodeficiency virus 1 infection
aml05171
Coronavirus disease - COVID-19
aml05200
Pathways in cancer
aml05205
Proteoglycans in cancer
aml05206
MicroRNAs in cancer
aml05214
Glioma
aml05223
Non-small cell lung cancer
aml05225
Hepatocellular carcinoma
aml05231
Choline metabolism in cancer
Brite
KEGG Orthology (KO) [BR:
aml00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100478007 (PRKCB)
04012 ErbB signaling pathway
100478007 (PRKCB)
04014 Ras signaling pathway
100478007 (PRKCB)
04015 Rap1 signaling pathway
100478007 (PRKCB)
04310 Wnt signaling pathway
100478007 (PRKCB)
04370 VEGF signaling pathway
100478007 (PRKCB)
04064 NF-kappa B signaling pathway
100478007 (PRKCB)
04066 HIF-1 signaling pathway
100478007 (PRKCB)
04020 Calcium signaling pathway
100478007 (PRKCB)
04070 Phosphatidylinositol signaling system
100478007 (PRKCB)
04071 Sphingolipid signaling pathway
100478007 (PRKCB)
04150 mTOR signaling pathway
100478007 (PRKCB)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
100478007 (PRKCB)
04540 Gap junction
100478007 (PRKCB)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
100478007 (PRKCB)
04650 Natural killer cell mediated cytotoxicity
100478007 (PRKCB)
04662 B cell receptor signaling pathway
100478007 (PRKCB)
04666 Fc gamma R-mediated phagocytosis
100478007 (PRKCB)
04670 Leukocyte transendothelial migration
100478007 (PRKCB)
04062 Chemokine signaling pathway
100478007 (PRKCB)
09152 Endocrine system
04911 Insulin secretion
100478007 (PRKCB)
04929 GnRH secretion
100478007 (PRKCB)
04912 GnRH signaling pathway
100478007 (PRKCB)
04921 Oxytocin signaling pathway
100478007 (PRKCB)
04935 Growth hormone synthesis, secretion and action
100478007 (PRKCB)
04918 Thyroid hormone synthesis
100478007 (PRKCB)
04919 Thyroid hormone signaling pathway
100478007 (PRKCB)
04928 Parathyroid hormone synthesis, secretion and action
100478007 (PRKCB)
04916 Melanogenesis
100478007 (PRKCB)
04925 Aldosterone synthesis and secretion
100478007 (PRKCB)
09153 Circulatory system
04270 Vascular smooth muscle contraction
100478007 (PRKCB)
09154 Digestive system
04970 Salivary secretion
100478007 (PRKCB)
04971 Gastric acid secretion
100478007 (PRKCB)
04972 Pancreatic secretion
100478007 (PRKCB)
04973 Carbohydrate digestion and absorption
100478007 (PRKCB)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100478007 (PRKCB)
04961 Endocrine and other factor-regulated calcium reabsorption
100478007 (PRKCB)
09156 Nervous system
04724 Glutamatergic synapse
100478007 (PRKCB)
04727 GABAergic synapse
100478007 (PRKCB)
04725 Cholinergic synapse
100478007 (PRKCB)
04728 Dopaminergic synapse
100478007 (PRKCB)
04726 Serotonergic synapse
100478007 (PRKCB)
04720 Long-term potentiation
100478007 (PRKCB)
04730 Long-term depression
100478007 (PRKCB)
04723 Retrograde endocannabinoid signaling
100478007 (PRKCB)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100478007 (PRKCB)
09159 Environmental adaptation
04713 Circadian entrainment
100478007 (PRKCB)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100478007 (PRKCB)
05206 MicroRNAs in cancer
100478007 (PRKCB)
05205 Proteoglycans in cancer
100478007 (PRKCB)
05231 Choline metabolism in cancer
100478007 (PRKCB)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
100478007 (PRKCB)
05214 Glioma
100478007 (PRKCB)
05223 Non-small cell lung cancer
100478007 (PRKCB)
09164 Neurodegenerative disease
05017 Spinocerebellar ataxia
100478007 (PRKCB)
05022 Pathways of neurodegeneration - multiple diseases
100478007 (PRKCB)
09165 Substance dependence
05031 Amphetamine addiction
100478007 (PRKCB)
05032 Morphine addiction
100478007 (PRKCB)
09167 Endocrine and metabolic disease
04931 Insulin resistance
100478007 (PRKCB)
04933 AGE-RAGE signaling pathway in diabetic complications
100478007 (PRKCB)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100478007 (PRKCB)
05161 Hepatitis B
100478007 (PRKCB)
05171 Coronavirus disease - COVID-19
100478007 (PRKCB)
05164 Influenza A
100478007 (PRKCB)
05163 Human cytomegalovirus infection
100478007 (PRKCB)
09174 Infectious disease: parasitic
05146 Amoebiasis
100478007 (PRKCB)
05140 Leishmaniasis
100478007 (PRKCB)
05143 African trypanosomiasis
100478007 (PRKCB)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100478007 (PRKCB)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
aml01001
]
100478007 (PRKCB)
Enzymes [BR:
aml01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.13 protein kinase C
100478007 (PRKCB)
Protein kinases [BR:
aml01001
]
Serine/threonine kinases: AGC group
PKC family [OT]
100478007 (PRKCB)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
C1_1
C2
Pkinase_C
C1_2
Kinase-like
CEP76-C2
APH
Motif
Other DBs
NCBI-GeneID:
100478007
NCBI-ProteinID:
XP_011232297
Ensembl:
ENSAMEG00000014177
LinkDB
All DBs
Position
10
AA seq
671 aa
AA seq
DB search
MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGF
GKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPTFCDHCGS
LLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIEREVLIVVVRDA
KNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRL
SVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEE
LRQKFERAKISQGTKAPEEKTTNTISKLDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSE
RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM
EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI
KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP
FEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF
RYIDWEKLERKEIQPPYKPKARDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGF
SYTNPEFVINV
NT seq
2016 nt
NT seq
+upstream
nt +downstream
nt
atggctgacccggctgcggggccgccgccgagcgagggcgaggagagcaccgtgcgcttc
gcccgcaaaggcgccctccgacagaagaacgtgcacgaggtgaagaaccacaaattcact
gcccgcttcttcaagcagcccacattctgcagccactgcaccgacttcatctggggcttc
ggaaagcaaggattccagtgccaagtctgctgttttgttgtgcacaagcggtgccatgaa
tttgtcaccttctcctgcccaggcgccgacaaaggcccagcctccgatgacccccggagc
aaacacaagtttaagatccacacgtactccagccccacgttttgtgaccactgtgggtca
ctgctgtatggactcatccaccaggggatgaagtgtgacacctgcatgatgaacgtgcac
aagcgctgcgtgatgaacgtccccagcctgtgcggcacagaccacacggagcgccgcggc
cgcatctacatccaggcccacatcgagagggaagtcctcattgtagtcgtaagagatgct
aaaaaccttgtacctatggaccccaatggcttgtcagacccttacgtgaaactaaaactg
attcctgaccccaagagcgagagcaagcagaagaccaaaaccatcaagtgctccctcaac
cctgagtggaatgagacattcagattccaactgaaagaatcggacaaagacagaagactg
tctgtagagatttgggattgggatctgaccagcaggaatgacttcatgggatctttgtcg
tttgggatttccgaactgcagaaagctggtgttgatggctggtttaagctgctgagccag
gaggaaggcgaatacttcaatgtgcctgtgccgccggaaggaagcgaaggcaatgaagag
ctgcggcagaaattcgagagggccaagatcagtcaggggaccaaggctccagaagaaaag
acgaccaacaccatatccaaacttgacaacaacgggaacagagaccgaatgaaactgacc
gattttaacttcctgatggtgctcgggaaaggaagctttggaaaggtcatgctctctgag
cgaaaaggcacggacgagctctatgccgtgaagatcctgaagaaggacgtcgtgatccag
gatgacgatgtggagtgcacgatggtggagaagcgggtgctggccctgcctgggaagccg
ccattcctgacccaactgcattcctgcttccagaccatggaccgcctgtactttgtgatg
gagtatgtgaacgggggcgacctcatgtaccacatccaacaagtcggccggtttaaggag
cctcatgctgtattttacgctgcagaaattgccatcggtctgttcttcttacagagcaag
ggcatcatttaccgtgacctcaaacttgacaatgtgatgctggattcagagggccacatc
aagattgctgattttggcatgtgcaaagaaaacatctgggatggggtgaccaccaagaca
ttctgtggcactccagactacatcgcccctgagatcattgcctaccagccctatgggaag
tctgtggattggtgggccttcggagtcctgctgtacgaaatgttggctgggcaggcaccc
tttgaaggggaggatgaggatgagctcttccagtccatcatggaacacaatgtggcttac
cccaagtccatgtccaaggaagctgtggccatctgcaaagggctgatgaccaaacacccg
ggcaaacgtctgggttgcggacccgaaggtgaacgtgacatcaaggagcatgcgtttttc
cggtatattgattgggagaaacttgaacgcaaagagattcagcccccgtataagccaaaa
gccagagacaagcgagacacctccaacttcgacaaagagttcaccagacagcctgtggaa
ctcacgcctaccgataaactcttcatcatgaacttggaccaaaatgaatttgctggcttc
tcctatactaacccagagtttgtcattaatgtgtag
Ailuropoda melanoleuca (giant panda): 100484719
Help
Entry
100484719 CDS
T01329
Gene name
PRKCG
Definition
(RefSeq) protein kinase C gamma type isoform X1
KO
K19663
classical protein kinase C gamma type [EC:
2.7.11.13
]
Organism
aml
Ailuropoda melanoleuca (giant panda)
Pathway
aml01521
EGFR tyrosine kinase inhibitor resistance
aml04010
MAPK signaling pathway
aml04012
ErbB signaling pathway
aml04014
Ras signaling pathway
aml04015
Rap1 signaling pathway
aml04020
Calcium signaling pathway
aml04066
HIF-1 signaling pathway
aml04070
Phosphatidylinositol signaling system
aml04071
Sphingolipid signaling pathway
aml04150
mTOR signaling pathway
aml04270
Vascular smooth muscle contraction
aml04310
Wnt signaling pathway
aml04370
VEGF signaling pathway
aml04510
Focal adhesion
aml04540
Gap junction
aml04613
Neutrophil extracellular trap formation
aml04650
Natural killer cell mediated cytotoxicity
aml04666
Fc gamma R-mediated phagocytosis
aml04670
Leukocyte transendothelial migration
aml04713
Circadian entrainment
aml04720
Long-term potentiation
aml04723
Retrograde endocannabinoid signaling
aml04724
Glutamatergic synapse
aml04725
Cholinergic synapse
aml04726
Serotonergic synapse
aml04727
GABAergic synapse
aml04728
Dopaminergic synapse
aml04730
Long-term depression
aml04750
Inflammatory mediator regulation of TRP channels
aml04911
Insulin secretion
aml04916
Melanogenesis
aml04918
Thyroid hormone synthesis
aml04919
Thyroid hormone signaling pathway
aml04921
Oxytocin signaling pathway
aml04925
Aldosterone synthesis and secretion
aml04928
Parathyroid hormone synthesis, secretion and action
aml04929
GnRH secretion
aml04935
Growth hormone synthesis, secretion and action
aml04960
Aldosterone-regulated sodium reabsorption
aml04961
Endocrine and other factor-regulated calcium reabsorption
aml04970
Salivary secretion
aml04971
Gastric acid secretion
aml04972
Pancreatic secretion
aml05017
Spinocerebellar ataxia
aml05022
Pathways of neurodegeneration - multiple diseases
aml05031
Amphetamine addiction
aml05032
Morphine addiction
aml05143
African trypanosomiasis
aml05146
Amoebiasis
aml05161
Hepatitis B
aml05163
Human cytomegalovirus infection
aml05170
Human immunodeficiency virus 1 infection
aml05171
Coronavirus disease - COVID-19
aml05200
Pathways in cancer
aml05205
Proteoglycans in cancer
aml05206
MicroRNAs in cancer
aml05214
Glioma
aml05223
Non-small cell lung cancer
aml05225
Hepatocellular carcinoma
aml05231
Choline metabolism in cancer
Brite
KEGG Orthology (KO) [BR:
aml00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100484719 (PRKCG)
04012 ErbB signaling pathway
100484719 (PRKCG)
04014 Ras signaling pathway
100484719 (PRKCG)
04015 Rap1 signaling pathway
100484719 (PRKCG)
04310 Wnt signaling pathway
100484719 (PRKCG)
04370 VEGF signaling pathway
100484719 (PRKCG)
04066 HIF-1 signaling pathway
100484719 (PRKCG)
04020 Calcium signaling pathway
100484719 (PRKCG)
04070 Phosphatidylinositol signaling system
100484719 (PRKCG)
04071 Sphingolipid signaling pathway
100484719 (PRKCG)
04150 mTOR signaling pathway
100484719 (PRKCG)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
100484719 (PRKCG)
04540 Gap junction
100484719 (PRKCG)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
100484719 (PRKCG)
04650 Natural killer cell mediated cytotoxicity
100484719 (PRKCG)
04666 Fc gamma R-mediated phagocytosis
100484719 (PRKCG)
04670 Leukocyte transendothelial migration
100484719 (PRKCG)
09152 Endocrine system
04911 Insulin secretion
100484719 (PRKCG)
04929 GnRH secretion
100484719 (PRKCG)
04921 Oxytocin signaling pathway
100484719 (PRKCG)
04935 Growth hormone synthesis, secretion and action
100484719 (PRKCG)
04918 Thyroid hormone synthesis
100484719 (PRKCG)
04919 Thyroid hormone signaling pathway
100484719 (PRKCG)
04928 Parathyroid hormone synthesis, secretion and action
100484719 (PRKCG)
04916 Melanogenesis
100484719 (PRKCG)
04925 Aldosterone synthesis and secretion
100484719 (PRKCG)
09153 Circulatory system
04270 Vascular smooth muscle contraction
100484719 (PRKCG)
09154 Digestive system
04970 Salivary secretion
100484719 (PRKCG)
04971 Gastric acid secretion
100484719 (PRKCG)
04972 Pancreatic secretion
100484719 (PRKCG)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
100484719 (PRKCG)
04961 Endocrine and other factor-regulated calcium reabsorption
100484719 (PRKCG)
09156 Nervous system
04724 Glutamatergic synapse
100484719 (PRKCG)
04727 GABAergic synapse
100484719 (PRKCG)
04725 Cholinergic synapse
100484719 (PRKCG)
04728 Dopaminergic synapse
100484719 (PRKCG)
04726 Serotonergic synapse
100484719 (PRKCG)
04720 Long-term potentiation
100484719 (PRKCG)
04730 Long-term depression
100484719 (PRKCG)
04723 Retrograde endocannabinoid signaling
100484719 (PRKCG)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
100484719 (PRKCG)
09159 Environmental adaptation
04713 Circadian entrainment
100484719 (PRKCG)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100484719 (PRKCG)
05206 MicroRNAs in cancer
100484719 (PRKCG)
05205 Proteoglycans in cancer
100484719 (PRKCG)
05231 Choline metabolism in cancer
100484719 (PRKCG)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
100484719 (PRKCG)
05214 Glioma
100484719 (PRKCG)
05223 Non-small cell lung cancer
100484719 (PRKCG)
09164 Neurodegenerative disease
05017 Spinocerebellar ataxia
100484719 (PRKCG)
05022 Pathways of neurodegeneration - multiple diseases
100484719 (PRKCG)
09165 Substance dependence
05031 Amphetamine addiction
100484719 (PRKCG)
05032 Morphine addiction
100484719 (PRKCG)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100484719 (PRKCG)
05161 Hepatitis B
100484719 (PRKCG)
05171 Coronavirus disease - COVID-19
100484719 (PRKCG)
05163 Human cytomegalovirus infection
100484719 (PRKCG)
09174 Infectious disease: parasitic
05146 Amoebiasis
100484719 (PRKCG)
05143 African trypanosomiasis
100484719 (PRKCG)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100484719 (PRKCG)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
aml01001
]
100484719 (PRKCG)
Enzymes [BR:
aml01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.13 protein kinase C
100484719 (PRKCG)
Protein kinases [BR:
aml01001
]
Serine/threonine kinases: AGC group
PKC family [OT]
100484719 (PRKCG)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
C1_1
PK_Tyr_Ser-Thr
C2
Pkinase_C
Kinase-like
Motif
Other DBs
NCBI-GeneID:
100484719
NCBI-ProteinID:
XP_002927999
Ensembl:
ENSAMEG00000004418
UniProt:
D2HYP8
LinkDB
All DBs
Position
12
AA seq
697 aa
AA seq
DB search
MAGLGPGGGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIG
KQGLQCQVCSFVVHRRCHEFVTFECPGAGKGPQTDDPRNKHKFRLHSYSSPTFCDHCGSL
LYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHTERRGRLQLEIRAPTADEIHVTVGEA
RNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTRTVKATLNPVWNETFVFNLKPGDVERRL
SVEVWDWDRTSRNDFMGAMSFGVSELLKAPVDGWYKLLNQEEGEYYNVPVADADNCSLLQ
KFEACNYPLELYERVRMGPSSSPIPSPSPSPTDSKRCFFGTSPGRLHISDFSFLMVLGKG
SFGKVMLAERRGSDELYAIKILKKDVIVQDDDVDCTLVEKRVLALGGRGPGGRPHFLTQL
HSTFQTPDRLYFVMEYVTGGDLMYHIQQLGKFKEPHAAFYAAEIAIGLFFLHNQGIIYRD
LKLDNVMLDAEGHIKITDFGMCKENVFPGTTTRTFCGTPDYIAPEIIAYQPYGKSVDWWS
FGVLLYEMLAGQPPFDGEDEEELFQAIMEQTVTYPKSLSREAVAICKGFLTKHPAKRLGS
GPDGEPAIRAHGFFRWMDWERLERLEIAPPFRPRPCGRSGENFDKFFTRAAPALTPPDRL
VLASIDQADFQGFTYVNPDFVHPDARSPISPPPVPVM
NT seq
2094 nt
NT seq
+upstream
nt +downstream
nt
atggcaggcctgggccccggcggaggcgattcagaggggggaccccggcccctgttttgc
agaaagggggctctgaggcagaaggtggtccacgaagtcaagagccacaagttcaccgcc
cgcttcttcaagcagccaaccttctgcagccactgcaccgacttcatctggggaattgga
aaacagggcctgcaatgtcaagtctgcagctttgtggttcatcgacgatgccacgaattt
gtgaccttcgagtgtccaggcgctgggaagggcccccagacggatgacccccggaacaag
cacaagttccgtctgcacagctacagcagccccaccttttgcgaccactgcggctccctc
ctctacgggctggtgcaccagggcatgaaatgctcctgctgcgagatgaacgtgcaccga
cgctgtgtgcgcagcgtgccctctctgtgcggggtggaccacaccgagcgccgtgggcgc
ctgcagctggaaatccgggcaccgacggcagatgagatacacgtcacagttggcgaggcc
cgtaacctcatcccgatggatcccaatggtctgtctgatccctatgtgaagctgaagctc
atcccagaccctcggaacttgacgaaacagaagacccgaacagtgaaagccacactaaac
cctgtgtggaacgagacctttgtgttcaacttgaagccgggggacgtggagcgccggctc
agcgtggaggtgtgggactgggaccggacttcccgcaatgatttcatgggtgccatgtcc
ttcggtgtctcggagctgctcaaggcgccggtggacggctggtacaagttactgaaccag
gaggagggcgagtattacaatgtgccggtggctgacgctgacaactgcagcctcctccag
aaatttgaggcctgtaactacccactggaactgtatgagcgggtgcggatgggtccctct
tcgtctcccatcccttccccatcccccagtcccaccgactccaagcgctgtttctttggg
acaagccctggacgtctgcacatctctgacttcagcttcctcatggttctaggaaaaggc
agttttgggaaggtgatgctggctgagcgcaggggctccgatgagctctacgccatcaag
atcctgaagaaagacgtgattgttcaggatgacgacgtggactgcaccctggtggagaag
cgagtgctggccctggggggccgaggcccgggcggccggccccactttctcacccagctg
cattcgaccttccagaccccggatcgcctgtattttgtgatggagtatgtcacggggggc
gacctgatgtaccacatccagcagttgggcaagtttaaggagccccatgcagcgttctac
gcagcggaaatcgccatcggcctcttcttccttcacaatcagggcatcatctaccgggac
ctgaaactagacaacgtgatgctggacgcagaaggacacatcaaaatcacggacttcggc
atgtgtaaggagaacgtcttccccgggaccacgacccgcaccttctgcgggaccccagac
tacatagcccctgagatcattgcctaccagccctatgggaagtctgtggattggtggtcc
tttggggttctgctgtatgagatgctggcaggacagcccccttttgacggggaggatgag
gaagagctgtttcaggccatcatggaacaaactgtcacttaccccaagtcactttcccgg
gaagccgtggcgatctgcaaggggttcctaactaagcacccagcgaagcgcctgggctcg
gggccagacggggagcccgccatccgtgctcatggctttttccgctggatggactgggag
cgcctggaacgactggagatcgcgcctccgttcagaccccgtccgtgtggacgcagcggt
gagaacttcgacaaattcttcacgcgggcggcgccagcgctgaccccgccagaccgccta
gtgttggccagcatcgaccaggccgatttccaaggcttcacctacgtgaacccggatttc
gtgcacccagatgcccgcagccccatcagccctccgcctgtgccagtcatgtaa
DBGET
integrated database retrieval system